AchilleS Vaccines
Advancing Vaccines & Immunotherapies for Global Health
AchilleS Vaccines is a biotechnology company dedicated to the research,
development, and innovation of vaccines and monoclonal antibodies targeting
infectious diseases and antimicrobial resistance.
Our mission is to deliver safe, effective, and scalable immunological solutions
that address some of the most urgent global health challenges.
AchilleS Vaccines
Advancing Vaccines & Immunotherapies for Global Health
AchilleS Vaccines is a biotechnology company dedicated to the research,
development, and innovation of vaccines and monoclonal antibodies targeting
infectious diseases and antimicrobial resistance.
Our mission is to deliver safe, effective, and scalable immunological solutions
that address some of the most urgent global health challenges.
Our Vision
We envision a future where preventable infectious diseases no longer threaten global health, and where innovation in vaccinology enables rapid response to emerging pathogens.
AchilleS Vaccines strives to become a trusted partner in global vaccine development, contributing to healthier communities and stronger healthcare systems.
Scientific Expertise
AchilleS Vaccines brings together multidisciplinary expertise across:
- Vaccine design and formulation
- Monoclonal antibody development
- Immunology and microbiology
- Translational and preclinical research
- Process development and scalability
Technology Platforms
We develop and optimize innovative platforms to support vaccine and antibody development, including:
- Recombinant antigen technologies
- Outer membrane vesicle (OMV)-based approaches
- Next-generation immunotherapy strategies
- Data-driven and in-silico-supported development models
Research & Development
Our R&D programs focus on high-impact infectious diseases, with particular attention to:
- Antimicrobial-resistant pathogens
- Emerging and re-emerging infectious diseases
- Pandemic preparedness
- Global unmet medical needs
Innovation & Partnerships
AchilleS Vaccines believes collaboration is essential for success. We actively engage with:
- Academic research centers
- Biotech and pharmaceutical partners
- Technology providers
- Global health organizations
Commitment to Quality & Ethics
We operate according to international scientific and ethical standards, ensuring:
- Rigorous safety and quality controls
- Responsible research practices
- Transparency and regulatory compliance
- Sustainable and ethical innovation
Global Impact
By addressing diseases with high global burden, AchilleS Vaccines contributes to:
- Improved public health outcomes
- Reduced healthcare costs
- Stronger pandemic preparedness
- Long-term global resilience
Our work supports international efforts to protect vulnerable populations worldwide.
Our Vision
We envision a future where preventable infectious diseases no longer threaten global health, and where innovation in vaccinology enables rapid response to emerging pathogens.
AchilleS Vaccines strives to become a trusted partner in global vaccine development, contributing to healthier communities and stronger healthcare systems.
Scientific Expertise
AchilleS Vaccines brings together multidisciplinary expertise across:
- Vaccine design and formulation
- Monoclonal antibody development
- Immunology and microbiology
- Translational and preclinical research
- Process development and scalability
Technology Platforms
We develop and optimize innovative platforms to support vaccine and antibody development, including:
- Recombinant antigen technologies
- Outer membrane vesicle (OMV)-based approaches
- Next-generation immunotherapy strategies
- Data-driven and in-silico-supported development models
Research & Development
Our R&D programs focus on high-impact infectious diseases, with particular attention to:
- Antimicrobial-resistant pathogens
- Emerging and re-emerging infectious diseases
- Pandemic preparedness
- Global unmet medical needs
Innovation & Partnerships
AchilleS Vaccines believes collaboration is essential for success. We actively engage with:
- Academic research centers
- Biotech and pharmaceutical partners
- Technology providers
- Global health organizations
Commitment to Quality & Ethics
We operate according to international scientific and ethical standards, ensuring:
- Rigorous safety and quality controls
- Responsible research practices
- Transparency and regulatory compliance
- Sustainable and ethical innovation
Global Impact
By addressing diseases with high global burden, AchilleS Vaccines contributes to:
- Improved public health outcomes
- Reduced healthcare costs
- Stronger pandemic preparedness
- Long-term global resilience
Our work supports international efforts to protect vulnerable populations worldwide.